This research studies how well Ayurvedic medicines(Ayorajvyoshaadya Churna, Phaltrikaadi Kwatha)and Panchkarma therapy (virechan karma) work in improving anaemia.

An Open Label Randomised Controlled Clinical Study to evaluate the efficacy of Ayorajvyoshaadya Churna,Phaltrikaadi Kwatha and Virechana Karma in the Management of Pandu Roga w.s.r. to Iron Deficiency Anaemia - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100953

Enrollment

Registered

2026-01-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Individuals of either gender between the age of 18-60 years. 2 Patients who present with sign and symptoms of Pandu Roga w.s.r. to Iron Deficiency Anaemia as described in classical texts. 3 Patients having low haemoglobin concentration i.e. Hb gm% for male 8-12gm% and female 8-11gm%. 4 MCV - below 70fl 5 Patients willing and able to participate for 12weeks duration.

Exclusion criteria

Exclusion criteria: 1 Patients suffering from chronic respiratory, cardiac disorder, CKD, Diabetes Mellitus, Rheumatoid Arthritis 2 Patients suffering from other major illness like carcinoma, tuberculosis or any other condition considered to be unfit for enrolment on the trial. 3 Hb lessthan 8 gm per dl. 4 Iron deficiency due to loss of blood from intestine& other sites. 5 Iron deficiency anaemia necessitates parental iron therapy. 6 Intake of Iron supplement for 3months before the initiation of study. 7 Participant with hepatic dysfunction (defined as AST &ALT, 2 times more of upper limit). 8 Participant with renal dysfunction i.e., S. creatinine level should not be more than 1.2mg per dl. 9 Patients who are pregnant and lactating mothers 10 History of hypersensitivity to any of the trial drug or its ingredients. 11 Individuals who have completed participation in any other clinical trial during the past three months. 12 History of active substance abuse 13 Any other condition which the principal investigator thinks may jeopardize the study

Design outcomes

Primary

Measure	Time frame
To clinically evaluate the efficacy of Ayorajvyoshaadya Churna, Phaltrikaadi Kwatha and Virechana Karma in the management of Pandu Roga w.s.r. to Iron Deficiency Anaemia.Timepoint: 12 weeks	—

Secondary

Measure	Time frame
To compare the efficacy of Ayorajvyoshaadya Churna, Phaltrikaadi Kwatha and Virechana Karma with Tablet Ferrous sulphate in the management of Pandu Roga w.s.r. to Iron Deficiency Anaemia. To assess the clinical safety and untoward effects of Ayorajvyoshaadya Churna and Phaltrikaadi Kwatha and Virechana Karma in patients of Pandu Roga w.s.r. to Iron Deficiency Anaemia. Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactIshani Kaushal

Rajiv Gandhi Govt Post Graduate Ayuvedic College and Hospital Paprola

drvijaychaudhary@gmail.com09418130228

Outcome results